Sofia Guerreiro Cruz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sofia Guerreiro Cruz has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Ana Azevedo
Hospital of Vila Franca de Xira Lisboa, Portugal
2 shared publicationsAna Isabel Oliveira
Hospital of Vila Franca de Xira Lisboa, Portugal
2 shared publications- Carolina Gomes
Hospital of Vila Franca de Xira Lisboa, Portugal
2 shared publications João Barbosa Barroso
Hospital of Vila Franca de Xira Lisboa, Portugal
2 shared publicationsLiliana Cunha
Hospital of Vila Franca de Xira Lisboa, Portugal
2 shared publications- Ana Cláudia Carvalho
Hospital de Braga, Sete Fontes—São Victor, 4710-243 Braga, Portugal
1 shared publication
Latest Publications
- Open Access
- 12 June 2025
- Published by Elsevier in Nefrología (English Edition)
- Vol. 45 (5) , 397-400
Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion
- 12 June 2025
- Published by Elsevier in Nefrología (English Edition)
- Vol. 45 (5) , 397-400
Open AccessSevere hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion
- Open Access
- 10 January 2025
- Published by Elsevier in Nefrología
- Vol. 45 (5) , 397-400
Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion
- 10 January 2025
- Published by Elsevier in Nefrología
- Vol. 45 (5) , 397-400
Open AccessSevere hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion
- Open Access
- 18 April 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (4) , 819
Epidemiological and Clinical Aspects of Cutaneous and Mucosal Leishmaniases in Portugal: Retrospective Analysis of Cases Diagnosed in Public Hospitals and Reported in the Literature between 2010 and 2020
Leishmania infantum, a zoonotic vector-born parasite, is endemic in the Mediterranean region, presenting mostly as visceral (VL), but also as cutaneous (CL) and mucosal leishmaniasis (ML). This study aimed to describe the epidemiological and clinical aspects of the CL and ML cases diagnosed in mainland Portugal between 2010 and 2020. Collaboration was requested from every hospital of the Portuguese National Health System. Cases were screened through a search of diagnostic discharge codes or positive laboratory results for Leishmania infection. Simultaneously, a comprehensive literature search was performed. Descriptive statistics and hypothesis testing were performed using IBM® SPSS® Statistics. A total of 43 CL and 7 ML cases were identified, with a predominance of autochthonous cases (86%). In CL, immunosuppressed individuals constituted a significant proportion of patients (48%), and in this group, disseminated CL (22%) and simultaneous VL (54%) were common. In autochthonous cases, lesions, mostly papules/nodules (62%), were frequently observed on the head (48%). The approach to treatment was very heterogeneous. ML cases were all autochthonous, were diagnosed primarily in older immunosuppressed individuals, and were generally treated with liposomal amphotericin B. The findings suggest a need for enhanced surveillance and reporting, clinical awareness, and diagnostic capacity of these forms of leishmaniasis to mitigate underdiagnosis and improve patient outcomes. A holistic One Health approach is advocated to address the multifaceted challenges posed by leishmaniases in Portugal and beyond.
- 18 April 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (4) , 819
Open AccessEpidemiological and Clinical Aspects of Cutaneous and Mucosal Leishmaniases in Portugal: Retrospective Analysis of Cases Diagnosed in Public Hospitals and Reported in the Literature between 2010 and 2020
Leishmania infantum, a zoonotic vector-born parasite, is endemic in the Mediterranean region, presenting mostly as visceral (VL), but also as cutaneous (CL) and mucosal leishmaniasis (ML). This study aimed to describe the epidemiological and clinical aspects of the CL and ML cases diagnosed in mainland Portugal between 2010 and 2020. Collaboration was requested from every hospital of the Portuguese National Health System. Cases were screened through a search of diagnostic discharge codes or positive laboratory results for Leishmania infection. Simultaneously, a comprehensive literature search was performed. Descriptive statistics and hypothesis testing were performed using IBM® SPSS® Statistics. A total of 43 CL and 7 ML cases were identified, with a predominance of autochthonous cases (86%). In CL, immunosuppressed individuals constituted a significant proportion of patients (48%), and in this group, disseminated CL (22%) and simultaneous VL (54%) were common. In autochthonous cases, lesions, mostly papules/nodules (62%), were frequently observed on the head (48%). The approach to treatment was very heterogeneous. ML cases were all autochthonous, were diagnosed primarily in older immunosuppressed individuals, and were generally treated with liposomal amphotericin B. The findings suggest a need for enhanced surveillance and reporting, clinical awareness, and diagnostic capacity of these forms of leishmaniasis to mitigate underdiagnosis and improve patient outcomes. A holistic One Health approach is advocated to address the multifaceted challenges posed by leishmaniases in Portugal and beyond.
- Open Access
- 2 March 2021
- Published by MDPI AG in Clinics and Practice
- Vol. 11 (1) , 162-166
Mitral Valve Subacute Endocarditis Caused by Abiotrophia Defectiva: A Case Report
Abiotrophia defectiva is a rare agent of endocarditis and subacute presentation may delay the diagnosis. We present the case of a 41-year-old male who was admitted to the hospital for further investigation regarding a consumptive syndrome with microcytic anaemia. Past medical history included new-onset mitral insufficiency followed by an ischaemic stroke due to small vessel disease. Thoraco-abdominal computed tomography revealed a splenic infarction. In the presence of two ischaemic events associated with mitral valve disease of unknown aetiology, we considered the possibility of subacute endocarditis. Blood cultures were positive for Abiotrophia defectiva, and transoesophageal echocardiography confirmed the diagnosis. As a subacute presentation of endocarditis, the paucity of symptoms caused a five-month delay in diagnosis. New-onset valvular disease and a stroke in an otherwise healthy young patient should always prompt proper investigation. This case highlights several complications caused by septic emboli of undiagnosed and untreated endocarditis.
- 2 March 2021
- Published by MDPI AG in Clinics and Practice
- Vol. 11 (1) , 162-166
Open AccessMitral Valve Subacute Endocarditis Caused by Abiotrophia Defectiva: A Case Report
Abiotrophia defectiva is a rare agent of endocarditis and subacute presentation may delay the diagnosis. We present the case of a 41-year-old male who was admitted to the hospital for further investigation regarding a consumptive syndrome with microcytic anaemia. Past medical history included new-onset mitral insufficiency followed by an ischaemic stroke due to small vessel disease. Thoraco-abdominal computed tomography revealed a splenic infarction. In the presence of two ischaemic events associated with mitral valve disease of unknown aetiology, we considered the possibility of subacute endocarditis. Blood cultures were positive for Abiotrophia defectiva, and transoesophageal echocardiography confirmed the diagnosis. As a subacute presentation of endocarditis, the paucity of symptoms caused a five-month delay in diagnosis. New-onset valvular disease and a stroke in an otherwise healthy young patient should always prompt proper investigation. This case highlights several complications caused by septic emboli of undiagnosed and untreated endocarditis.